THE PENNANT GROUP, INC. Increase (Decrease) in Contract with Customer, Liability
THE PENNANT GROUP, INC. (PNTG) reported Increase (Decrease) in Contract with Customer, Liability of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2025-02-27
- THE PENNANT GROUP, INC. increase (decrease) in contract with customer, liability for the quarter ending 2023-12-31 was $0.00.
- THE PENNANT GROUP, INC. increase (decrease) in contract with customer, liability for the quarter ending 2023-09-30 was $0.00.
- THE PENNANT GROUP, INC. increase (decrease) in contract with customer, liability for the quarter ending 2023-06-30 was $0.00.
- THE PENNANT GROUP, INC. increase (decrease) in contract with customer, liability for the quarter ending 2023-03-31 was $0.00.
- THE PENNANT GROUP, INC. increase (decrease) in contract with customer, liability for fiscal 2024 was $0.00.
- THE PENNANT GROUP, INC. increase (decrease) in contract with customer, liability for fiscal 2023 was $0.00.
- THE PENNANT GROUP, INC. increase (decrease) in contract with customer, liability for fiscal 2022 was -$6.21M.
- THE PENNANT GROUP, INC. increase (decrease) in contract with customer, liability for fiscal 2021 was -$21.79M, a 177.82% decline from fiscal 2020.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-27 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | -$1.49M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | -$1.49M derived: sum of 3 quarters · filed 2025-02-27 | -$6.21M 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$1.49M derived: sum of 2 quarters · filed 2023-11-07 | -$6.21M 10-Q · filed 2023-11-07 | -$13.36M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$6.21M 10-Q · filed 2023-08-08 | -$13.36M derived: sum of 3 quarters · filed 2024-02-28 | -$20.90M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$4.72M 10-Q · filed 2023-05-04 | -$11.87M derived: sum of 2 quarters · filed 2024-02-28 | -$19.41M derived: sum of 3 quarters · filed 2024-02-28 | -$26.51M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$7.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$14.69M derived: sum of 2 quarters · filed 2024-02-28 | -$21.79M derived: sum of 3 quarters · filed 2024-02-28 | -$21.79M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$7.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$14.64M derived: sum of 2 quarters · filed 2022-11-07 | -$14.64M 10-Q · filed 2022-11-07 | -$14.64M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | -$7.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$7.10M 10-Q · filed 2022-08-08 | -$7.10M derived: sum of 3 quarters · filed 2023-02-23 | -$7.10M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $0.00 derived: sum of 3 quarters · filed 2023-02-23 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $28.00M 10-K · filed 2023-02-23 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $28.00M 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | $28.00M 10-Q · filed 2021-08-09 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $0.00 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-11 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |